amgen glp-1 drug Amgen's obesity may help patients keep the weight off Nutritional priorities to support GLP-1

a second author disclosed ties to the legal industry

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study

Better vascular health protects the small vessels whose dysfunction drives white-matter damage

Patients who continued treatment with arGLP-1 sustained their excess weight loss over time, with positive outcomes observed even up to 34 years of continuous therapy

This advanced formula features targeted probiotic strains including Akkermansia muciniphila and Clostridium butyricum, organisms associated with gut barrier integrity, short-chain fatty acid production, and healthy microbiome diversity